Grant: CIHR Fellowship
McMaster University
$108,750.00
Regulation of embryonic stem cell self-renewal and differentiation by TCF-independent Beta-catenin signaling
FY 2009-10
Summary
Embryonic stem cells (ESCs) are specialized cells in the human body that have the ability to duplicate themselves (i.e. self-renew) while maintaining the potential to make any cell type, a quality called pluripotency. Although these cells hold great therapeutic promise because they may be capable of replacing diseased or damaged tissues, sometimes these cells can give rise to unwanted tumors. Thus, before these cells can be used in the clinic, it is imperative to more fully understand their properties, so that unwanted side effects can be avoided. To date, relatively little is known about the cellular pathways controlling stem cell properties. We have found that an enzyme called glycogen synthase kinase-3 (GSK-3) is an important regulator of ESC function. To provide insight into GSK-3's underlying mechanism of action, we have used cutting-edge techniques to create and analyze a panel of genetically modified ESCs. These ESC lines are integral tools to help accelerate the identification of new signaling molecules that are regulated by GSK-3. Understanding the function of GSK-3 in the regulation of stem cell properties will assist in taking stem cells from the laboratory to the clinic, where they will ultimately be used as therapeutic agents for tissue regeneration.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
203988
Name
Kelly Kevin F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Regulation of embryonic stem cell self-renewal and differentiation by TCF-independent Beta-catenin signaling
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$108,750
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer; Co-Immunoprecipitation; Differentiation; Embryonic Stem Cell; Mass Spectrometry; Microarray; Proteomics; Rnai; Self-Renewal; Signal Transduction
Abstract
Embryonic stem cells (ESCs) are specialized cells in the human body that have the ability to duplicate themselves (i.e. self-renew) while maintaining the potential to make any cell type, a quality called pluripotency. Although these cells hold great therapeutic promise because they may be capable of replacing diseased or damaged tissues, sometimes these cells can give rise to unwanted tumors. Thus, before these cells can be used in the clinic, it is imperative to more fully understand their properties, so that unwanted side effects can be avoided. To date, relatively little is known about the cellular pathways controlling stem cell properties. We have found that an enzyme called glycogen synthase kinase-3 (GSK-3) is an important regulator of ESC function. To provide insight into GSK-3's underlying mechanism of action, we have used cutting-edge techniques to create and analyze a panel of genetically modified ESCs. These ESC lines are integral tools to help accelerate the identification of new signaling molecules that are regulated by GSK-3. Understanding the function of GSK-3 in the regulation of stem cell properties will assist in taking stem cells from the laboratory to the clinic, where they will ultimately be used as therapeutic agents for tissue regeneration.
Competitiondate
201002
Approvedterm2
2 yrs 5 mths
Pinamesdelim
Kelly, Kevin F
Approvedterm
2 ans 5 mois
Cihrcontribution2
~ $108,750~ $0~